Dystrophic epidermolysis bullosa (DEB) is an inherited blistering skin disorder, characterized by mucocutaneous blistering, scarring and nail dystrophy following minor trauma. DEB is caused by mutations in the COL7A1 gene and occurs either as an autosomal dominant (DDEB, MIM 131750) or as a recessive (RDEB, MIM 226600) trait. The phenotypic variability results from the different types of mutations in COL7A1 and their positions within the gene. In most cases, RDEB has a more severe clinical presentation. 1 The most severe type of DEB, the recessive Hallopeau-Siemens variant (HS-RDEB), is caused by the presence of mutations that lead to premature termination codons (PTCs) in both alleles, whereas the autosomal dominant cases are frequently caused by heterozygous glycine substitutions (GSs) within the collagenous triple helix.To date, more than 500 different mutations of COL7A1 have been reported. 2 In this study, mutational analysis was performed in 18 distinct Korean families with DEB, and a computational study of each mutation was carried out. osa; TBDN, transient bullous dermolysis of the newborn; RDEB, recessive dystrophic epidermolysis bullosa; HS-RDEB, Hallopeau-Siemens RDEB; AS, alternative splicing; PTC, premature termination codon; GS, glycine substitution.
friends in school. The conditions of optimal treatment should be to destroy all the lesions, prevent recurrence and minimize scarring. To date, various methods, including excision, electrodessication with curettage, dermabrasion, and resurfacing with a CO 2 laser alone or in combination with trichloroacetic acid, have been tried. Our patient was treated with a CO 2 laser, and the lesions remained clear, without any scarring, 8 months later.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.